1. Home
  2. PFAI vs BOLD Comparison

PFAI vs BOLD Comparison

Compare PFAI & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PFAI

Pinnacle Food Group Limited

N/A

Current Price

$2.28

Market Cap

27.1M

ML Signal

N/A

Logo Boundless Bio Inc.

BOLD

Boundless Bio Inc.

HOLD

Current Price

$1.16

Market Cap

26.2M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
PFAI
BOLD
Founded
2015
2018
Country
Canada
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Sector
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
27.1M
26.2M
IPO Year
2025
2024

Fundamental Metrics

Financial Performance
Metric
PFAI
BOLD
Price
$2.28
$1.16
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$4.00
AVG Volume (30 Days)
8.6K
185.6K
Earning Date
12-26-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,497,672.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
28.80
N/A
52 Week Low
$1.30
$1.00
52 Week High
$4.93
$3.45

Technical Indicators

Market Signals
Indicator
PFAI
BOLD
Relative Strength Index (RSI) N/A 47.85
Support Level N/A $1.11
Resistance Level N/A $1.20
Average True Range (ATR) 0.00 0.07
MACD 0.00 0.01
Stochastic Oscillator 0.00 80.00

Price Performance

Historical Comparison
PFAI
BOLD

About PFAI Pinnacle Food Group Limited

Pinnacle Food Group Ltd is a provider of smart farming solutions focused on vertical and hydroponic farming. The company focuses on promoting sustainable food security by developing and building customized smart farming systems for customers based on the systematic integration of technology, hardware, and software, coupled with a full range of integrated supply and technical services. It sells hydroponic growing systems and technical support services to individual households and community groups, and is developing a hydroponic growing system for urban farms. Geographically, the company generates the majority revenue from Canada, followed by New Zealand.

About BOLD Boundless Bio Inc.

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

Share on Social Networks: